allylamine has been researched along with Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barabanova, A; Garcia, M; Paisansathan, C; Pelligrino, DA; Testai, F; Vetri, F; Xu, HL | 1 |
| Baughman, VL; Mao, L; Paisansathan, C; Pelligrino, DA; Vetri, F; Watcharotayangul, J; Xu, H | 1 |
2 other study(ies) available for allylamine and Nervous System Diseases
| Article | Year |
|---|---|
Pharmacologic blockade of vascular adhesion protein-1 lessens neurologic dysfunction in rats subjected to subarachnoid hemorrhage.
Topics: Allylamine; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion; Cell Adhesion Molecules; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Leukocytes; Male; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors | 2014 |
Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model.
Topics: Allylamine; Amine Oxidase (Copper-Containing); Animals; Brain Infarction; Cell Adhesion Molecules; Cell Movement; Cerebrovascular Circulation; Disease Models, Animal; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Leukocytes; Male; Microscopy, Confocal; Nervous System Diseases; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric | 2012 |